Suffolk Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Suffolk Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-481,490	Closed	-$1.55M	–	167
2016 Q1	$1.55M	Buy	481,490 +114,896	+31%	+$425K	0.21%	130
2015 Q4	$1.76M	Buy	+366,594	New	+$2.08M	0.22%	122
2015 Q3	–	Sell	-353,690	Closed	-$2.81M	–	163
2015 Q2	$2.81M	Buy	353,690 +118,794	+51%	+$1.02M	0.33%	83
2015 Q1	$2.47M	Buy	234,896 +18,896	+9%	+$258K	0.29%	111
2014 Q4	$2.6M	Buy	+216,000	New	+$3.28M	0.32%	107

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Suffolk Capital Management's BDSI Position: Q2 2016 in Review

Suffolk Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2016, closing a stake of 481,490 shares — an estimated $1.55M sold.

Suffolk Capital Management first reported a position in BDSI in Q4 2014 and held it in 5 quarters. The position peaked at $2.81M in Q2 2015. 88 funds tracked by Wall St. Rank hold BDSI as of Q2 2016.

Suffolk Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2016 after selling out during the quarter.
Suffolk Capital Management sold 481,490 BioDelivery Sciences International, Inc. shares in Q2 2016, an estimated $1.55M.
Suffolk Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 5 quarters.
Suffolk Capital Management's BioDelivery Sciences International, Inc. position peaked at $2.81M in Q2 2015.
88 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2016.

Based on Suffolk Capital Management's 13F filing for Q2 2016, filed 8 Aug 2016.